ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Psychiatry

Top Psychiatry Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CARMEN ZEGARRA MD

Psychiatry

1,728

$356K

292
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 26%

$206
Average prescription price

Avg: $147

MARY DARDEN MD

Psychiatry

5,675

$1.27M

239
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 26%

$223
Average prescription price

Avg: $147

GWILYM LODWICK MD

Psychiatry

4,469

$654K

265
13 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$146
Average prescription price

Avg: $147

SIOE TAN MD

Psychiatry

3,425

$291K

283
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

12%
prescriptions for brand name drugs

Avg: 26%

$85
Average prescription price

Avg: $147

DEBORAH ROOT MD

Psychiatry

2,110

$237K

123
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 26%

$112
Average prescription price

Avg: $147

RUSSELL BACH M.D.

Psychiatry

5,812

$1.11M

392
21 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 26%

$192
Average prescription price

Avg: $147

ANDREA IKEN TENNISON MD

Psychiatry

1,717

$265K

239
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 26%

$154
Average prescription price

Avg: $147

SARAH RASCO MD

Psychiatry

3,393

$681K

313
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 26%

$201
Average prescription price

Avg: $147

EDWARD LUKE D.O.

Psychiatry

3,465

$629K

139
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 26%

$182
Average prescription price

Avg: $147

GHULAM KHAN M.D.

Psychiatry

3,399

$560K

378
15 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

20%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$165
Average prescription price

Avg: $147

SARAH STREBECK MD

Psychiatry

2,021

$421K

100
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 26%

$208
Average prescription price

Avg: $147

JEFFREY JOSEPHS M.D.

Psychiatry

8,488

$1.7M

518
30 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$200
Average prescription price

Avg: $147

BEVERLY VANDERPOOL M.D.

Psychiatry

924

$212K

173
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 26%

$230
Average prescription price

Avg: $147

CHANTEE VAVASSEUR MD

Psychiatry

2,586

$339K

183
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

20%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 26%

$131
Average prescription price

Avg: $147

AKHTAR ALAM MD

Psychiatry

1,984

$233K

169
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 26%

$117
Average prescription price

Avg: $147

GERARD SCARDINO MD

Psychiatry

2,923

$451K

156
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

18%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 26%

$154
Average prescription price

Avg: $147

JAMES DOTTER M.D.

Psychiatry

3,939

$982K

305
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 26%

$249
Average prescription price

Avg: $147

MARK MCGRATH MD

Psychiatry

3,071

$490K

297
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$160
Average prescription price

Avg: $147

GUADALUPE ARANGUENA SHARPE M.D.

Psychiatry

1,782

$197K

140
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

21%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 26%

$110
Average prescription price

Avg: $147

GRETCHEN MEGOWEN M.D.

Psychiatry

4,646

$482K

589
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 26%

$104
Average prescription price

Avg: $147

PHYLLIS RAMIREZ M.D.

Psychiatry

2,250

$336K

161
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 26%

$149
Average prescription price

Avg: $147

JACK CHELEBIAN M.D.

Psychiatry

3,170

$755K

251
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

35%
prescriptions for brand name drugs

Avg: 26%

$238
Average prescription price

Avg: $147

CAMILLE POUSSON MD

Psychiatry

2,455

$591K

210
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 26%

$241
Average prescription price

Avg: $147

MICHELLE MERCADO MD

Psychiatry

4,525

$654K

335
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$145
Average prescription price

Avg: $147

DAVID O 'CONNOR MD

Psychiatry

3,245

$631K

181
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

38%
prescriptions for brand name drugs

Avg: 26%

$194
Average prescription price

Avg: $147

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank